NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

7669Listed tickers in the SEC universe 1972Issuers with current reporting periods 451Issuers with both EPS and ROE metrics 2026-09-20Fundamentals evaluated as of

Example screens

Example lists from a senior trader

Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

1972 companies match

Showing 501–550 of 1972 · page 11/40

Per page 2550100
CompanyCombined rankEPS accelerationRevenue growthROENet margin Reporting period
ACIWACI WORLDWIDE, INC.NASDAQ 191.1 pp 7.3% 2026-06-30Filed 2026-08-06
ACLSAXCELIS TECHNOLOGIES INCNASDAQ 42.4 pp 10.6% 2026-06-30Filed 2026-08-06
ACMAECOMNYSE -197.1 pp -14.2% 2026-06-30Filed 2026-08-11
ACMRACM Research, Inc.NASDAQ 199.5 pp 36.0% 2026-06-30Filed 2026-08-07
ACNBACNB CORPNASDAQ 4.5% 2026-06-30Filed 2026-08-06
ACNTASCENT INDUSTRIES CO.NASDAQ 37.6% 2026-06-30Filed 2026-08-04
ACOGAlpha Cognition Inc.NASDAQ 267.6% 2026-06-30Filed 2026-08-13
ACONAclarion, Inc.NASDAQ 30.5% 2026-06-30Filed 2026-08-06
ACRACRES Commercial Realty Corp.NYSE -4.1% 2026-06-30Filed 2026-08-04
ACREAres Commercial Real Estate CorpNYSE 14.3% -0.9% 2026-06-30Filed 2026-08-04
ACRSAclaris Therapeutics, Inc.NASDAQ -8.3% 2026-06-30Filed 2026-08-06
ACRVAcrivon Therapeutics, Inc.NASDAQ 2026-06-30Filed 2026-08-12
ACTEnact Holdings, Inc.NASDAQ 3.4 pp 4.1% 2026-06-30Filed 2026-08-06
ACTGACACIA RESEARCH CORPNASDAQ 123.6% 2026-06-30Filed 2026-08-06
ACTUACTUATE THERAPEUTICS, INC.NASDAQ 2026-06-30Filed 2026-08-14
ACUACME UNITED CORPNYSE 46.6 pp 16.1% 2026-06-30Filed 2026-08-06
ACVAACV Auctions Inc.NYSE 10.4% 2026-06-30Filed 2026-08-10
ACXPAcurx Pharmaceuticals, Inc.NASDAQ 2026-06-30Filed 2026-08-13
ADARRAY DIGITAL INFRASTRUCTURE, INC.NYSE 171.8 pp 89.5% 2026-06-30Filed 2026-08-07
ADACAmerican Drive Acquisition CoNASDAQ 2026-06-30Filed 2026-08-14
ADAMADAMAS TRUST, INC.NASDAQ 2026-06-30Filed 2026-07-31
ADBEADOBE INC.NASDAQ -3.2 pp 12.7% 2026-05-29Filed 2026-06-15
ADBTAdvasa Holdings, Inc.NASDAQ 23.3% 2026-06-30Filed 2026-08-12
ADCAGREE REALTY CORPNYSE -16.7 pp 16.8% 2026-06-30Filed 2026-07-30
ADCTADC Therapeutics SANYSE 3.0% 2026-06-30Filed 2026-08-13
ADEAAdeia Inc.NASDAQ -100.0 pp 12.1% 2026-06-30Filed 2026-08-05
ADGMAdagio Medical Holdings, Inc.NASDAQ 2026-06-30Filed 2026-08-11
ADIANALOG DEVICES INCNASDAQ 52.9 pp 39.6% 2026-08-01Filed 2026-08-19
ADIGADI GLOBAL DISTRIBUTION INC.NYSE 0.7% 2026-07-04Filed 2026-08-13
ADILADIAL PHARMACEUTICALS, INC.NASDAQ 2026-06-30Filed 2026-08-14
ADMArcher-Daniels-Midland CoNYSE 313.9 pp 0.7% 2026-06-30Filed 2026-08-04
ADMAADMA BIOLOGICS, INC.NASDAQ -58.4 pp 2.0% 2026-06-30Filed 2026-08-05
ADNTAdient plcNYSE 5.0% 2026-06-30Filed 2026-08-05
ADPAUTOMATIC DATA PROCESSING INCNASDAQ -1.0 pp 7.0% 2026-06-30Filed 2026-08-05
ADPTAdaptive Biotechnologies CorpNASDAQ 21.5% 2026-06-30Filed 2026-08-04
ADSKAutodesk, Inc.NASDAQ -171.8 pp 16.1% 2026-07-31Filed 2026-08-28
ADTADT Inc.NYSE 2.0% 2026-06-30Filed 2026-07-30
ADTNADTRAN Holdings, Inc.NASDAQ 6.1% 2026-06-30Filed 2026-08-04
ADUSAddus HomeCare CorpNASDAQ 6.9 pp 8.0% 2026-06-30Filed 2026-08-04
ADVAdvantage Solutions Inc.NASDAQ 1.8% 2026-06-30Filed 2026-08-05
ADVBAdvanced Biomed Inc.NASDAQ 2026-03-31Filed 2026-05-15
AEAQActivate Energy Acquisition Corp.NASDAQ 2026-06-30Filed 2026-08-12
AEBIAebi Schmidt Holding AGNASDAQ 78.7% 2026-06-30Filed 2026-08-13
AEEAMEREN CORPNYSE -7.7 pp -5.8% 2026-06-30Filed 2026-08-03
AEHRAEHR TEST SYSTEMSNASDAQ 2026-05-29Filed 2026-07-27
AEIAlset Inc.NASDAQ -10.0% 2026-06-30Filed 2026-08-14
AEISADVANCED ENERGY INDUSTRIES INCNASDAQ -52.0 pp 30.0% 2026-06-30Filed 2026-08-03
AEMDAETHLON MEDICAL INCNASDAQ 2026-06-30Filed 2026-08-13
AENTALLIANCE ENTERTAINMENT HOLDING CORPNASDAQ -3.6 pp 21.2% 2026-06-30Filed 2026-09-10
AEOAMERICAN EAGLE OUTFITTERS INCNYSE 7.5% 2026-08-01Filed 2026-09-10

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-09-18. Source: FRED / Federal Reserve.